ArticleBriefings in bioinformatics2024
CellMsg: graph convolutional networks for ligand-receptor-mediated cell-cell communication analysis.
Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Shared diagnostic biomarkers in metabolic syndrome and coronary artery disease identified by integrated bioinformatics and machine learning.Endocrine connections · 2026Article
- QSyncFold: quantum neural network for multidimensional sync-discovery in protein folding.Briefings in bioinformatics · 2026Article
- Spatial AI in cancer: mapping immune evasion topology through multi-modal omics and deep learning.Frontiers in oncology · 2026Review
- CELLetter: leveraging large language model and dual-stream network to identify context-specific ligand-receptor interactions for cell-cell communication analysis.Briefings in bioinformatics · 2025Article
- Understanding the molecular basis of herbal medicines for cough variant asthma under the guidance of traditional herbal theories.Frontiers in pharmacology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The role of cell-cell communications (CCCs) is increasingly recognized as being important to differentiation, invasion, metastasis, and drug resistance in tumoral tissues. Developing CCC inference methods using traditional experimental methods are time-consuming, labor-intensive, cannot handle large amounts of data. To facilitate inference of CCCs, we proposed a computational framework, called CellMsg, which involves two primary steps: identifying ligand-receptor interactions (LRIs) and measuring the strength of LRIs-mediated CCCs. Specifically, CellMsg first identifies high-confident LRIs based on multimodal features of ligands and receptors and graph convolutional networks. Then, CellMsg measures the strength of intercellular communication by combining the identified LRIs and single-cell RNA-seq data using a three-point estimation method. Performance evaluation on four benchmark LRI datasets by five-fold cross validation demonstrated that CellMsg accurately captured the relationships between ligands and receptors, resulting in the identification of high-confident LRIs. Compared with other methods of identifying LRIs, CellMsg has better prediction performance and robustness. Furthermore, the LRIs identified by CellMsg were successfully validated through molecular docking. Finally, we examined the overlap of LRIs between CellMsg and five other classical CCC databases, as well as the intercellular crosstalk among seven cell types within a human melanoma tissue. In summary, CellMsg establishes a complete, reliable, and well-organized LRI database and an effective CCC strength evaluation method for each single-cell RNA-seq data. It provides a computational tool allowing researchers to decipher intercellular communications. CellMsg is freely available at https://github.com/pengsl-lab/CellMsg.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.